(Free-Press-Release.com) January 19, 2010 -- Indian Drug Manufacturer’s Association, IDMA conferred the “Quality Excellence Award 2009” to VHB Medisciences Limited. The function was held at at Crystal Room, Taj Mahal Hotel on Saturday, January 16, 2010. VHB has won the award for its ultra-modern, one of its kind plant that has already received the WHO-GMP certification. It is also certified by INVIMA Colombia and NDA Uganda. The state of the art manufacturing plant is also in the final stages to obtain certification from ANVISA, UK MHRA & USFDA.
The ultra-modern plant with five independent units over 12 acres at Rudrapur matches current and future international regulations. The fully automated facility with leading edge technologies has been lauded by various visiting regulatory authorities and experts in the Pharmaceutical industry.
One of the fastest growing pharmaceutical groups in India, VHB manufactures and markets an extensive range of Oncology drugs, Critical Care Products, Plasma Products, Vaccines, High-end Antibiotics and Bulk Drugs. VHB is in the process of aggressively entering several international markets across continents. With all accreditations from key global agencies, the focus will remain providing the highest quality products and services.
VHB’s origins can be traced back to 1946, when Mr. Ramesh C. Bhagat began importing life saving drugs, vaccines, anticancer drugs, sutures and other critical products not available in India. VHB popularized the very concept of “preventive medicine” when they introduced several vaccines in India. VHB has contributed immensely to the fight against cancer by pioneering several anti-neoplastic drugs for the first time in India. VHB can also be called as one of the leaders in critical care medicine in India. Today, every intensive care unit in India uses one or many of VHB’s products.
With a long-term vision of becoming a key player in the global pharmaceutical scenario began the ambitious journey of building the most advanced pharmaceutical manufacturing unit. Today, that dream is a reality with the Injectable Antibiotic unit and Anti-cancer unit being fully operational. The hi-tech, environment-friendly unit has earned VHB the award for the “most technically & scientifically advanced Pharmaceutical Manufacturing unit” at the Pharmaceutical Leadership Summit 2009. For his immense contribution to the development of specialty healthcare in India, the chairman of VHB Group, Mr. Ramesh Bhagat also received the Lifetime Achievement Award at the summit.
With a team strength of over 1200 scientific, technical, sales and marketing personnel and more than 300 vital products, VHB is poised to consolidate its position and make inroads into several global markets.
The award is not just another feather in the cap for VHB. As Mr. Ramesh Bhagat put it “It is not just a recognition of excellence; it is a reminder of the tremendous responsibility we have to continue our meaningful contribution to critical, life-saving healthcare”.
